RAPT Therapeutics, Inc. (RAPT) Tops Q3 EPS by 9c

RAPT Therapeutics, Inc. (NASDAQ: RAPT) reported Q3 EPS of ($0.47), $0.09 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on RAPT Therapeutics, Inc. (RAPT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
• Nutrien warns shareholders about below-market mini-tender offer